Breaking News

An NFL widow and public health researcher on CTE

February 8, 2026
avatar-torie-bosch
First Opinion editor

This week, I learned that I forgot to sign my toddler up for dental coverage during open enrollment. My congenital guilt compels me to share that failure with all of you.

In better news, First Opinion published a fantastic range of authors. We had the big names: FormerHealth and Human Services Secretaries Donna Shalala and Tommy Thompson wrote an op-ed on Medicare Advantage, while former FDA Commissioner Robert Califf weighed in on the current administration's approach to evidence. And we also had some powerful first-person op-eds: from a public health researcher whose husband, a former NFL player, was diagnosed with chronic traumatic encephalitis after death; from a patient whose restless-leg syndrome medication apparently drove him to compulsive gambling; and from a pediatrician with a rare perspective: He has worked in both Denmark and the U.S., and argues that Denmark should learn from the U.S. on childhood vaccines, not the other way around.

Recommendation of the week: "Bugonia," with Emma Stone and Jesse Plemons — two of my favorite actors — is weird in the best way possible. (And don't miss Plemons' terrifying scene in "Civil War," either.)



Joe Raedle/Getty Images

I treated children for rotavirus in Denmark. The Danish vaccine schedule is no model for the U.S.

This pediatrician has worked in Denmark and the U.S. He thinks Denmark should learn from the U.S. on vaccines, not the other way around.

By Michael Thwing


Former FDA commissioner: HHS leadership is focused on policy-based evidence, not evidence-based policy

HHS leadership is focused on policy-based evidence, not evidence-based policy, writes former FDA Commissioner Robert Califf.

By Robert M. Califf


TrumpRx has a fundamental flaw

TrumpRx won't help the vast majority of Americans because it is designed for cash-paying, uninsured patients, experts write.

By Sean D. Sullivan and Ryan N. Hansen


Adobe

We helped create Medicare Advantage. Here's how to fix it

Two former HHS secretaries say Medicare Advantage is a vital program and policymakers must work to stabilize the program, not undermine it.

By Donna Shalala and Tommy G. Thompson


As a scientist and NFL widow, I am furious about a recent NFL Players Association-funded CTE study

Ahead of the Super Bowl, a scientist looks at an NFL Players Association funded study suggesting CTE "awareness" is the real problem.

By Eleanor M. Perfetto


Measles in an ICE facility is a public health failure

A measles outbreak in a Texas immigration detention center was foreseeable, preventable, and rooted in policy choices that neglect basic public health.

By Krutika Kuppalli


Justin Sullivan/Getty Images

I spent nearly 20 years on a drug for restless leg syndrome. It wrecked my life

Pramipexole for restless leg syndrome and Parkinson's can cause compulsive behaviors. Doctors don't always warn patients.

By J. Aaron Sanders


We asked whether principal investigators have plans in place for how research can continue without them

Our new research suggests that few PIs create plans for how their work can continue in their absence — even as Ph.D.s are fleeing the U.S.

By Annie L. Nguyen, David Seal, and Brandon Brown


Plain language abstracts can help reduce misuse of science

Clearly explaining a study's findings, implications, and limitations can help reduce the misuse of science.

By Kirstin R.W. Matthews and Heidi Russell


Haze from Canadian wildfires obscures buildings in the Rogers Park neighborhood of Chicago in June 2023.
Erin Hooley/AP

The EPA just erased a century of public health progress

By dropping lives saved from air pollution rules, the EPA breaks with a long tradition of valuing health over industry costs.

By Michelle A. Williams


How much should psychedelics researchers disclose about their personal use?

Many psychedelics researchers have personal experience with the drugs, creating some ethical dilemmas.

By Ian Reardon


STAT readers respond on the ethics of gender-affirming care for minors, the new food pyramid, and more

STAT readers fire back on the ethics of gender-affirming care for minors, the new food pyramid, and more.

By Torie Bosch


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments